A brand new cannabis extract has officially been put on shelves in at least one clinic in the United Kingdom. The product is named for Charlotte Figi, a child who experienced up to 300 grand mal seizures a week until her parents tried medical marijuana after traditional medications and treatments did not help. After the first dose of the oil extract, her condition improved drastically. About the miraculous turnaround, Charlotte’s father, Matt Figi stated:
“I want to scream it from the rooftops. I want other people, other parents, to know that this is a viable option.”
Thanks to legislation that was passed on July 31, more families and patients in the United Kingdom now have access to the product, which is affectionately known as “Charlotte’s Web.” UK CBD is the first company in Britain to sell the oil, and the company’s owner and CEO, Nicolas Ellis, said:
“[W]e are extremely proud to partner with CW Botanicals and to legally add their exclusive Charlotte’s Web products to our already impressive range. Their passion and dedication to making such high quality products is already well known globally.”
Ellis adds that not only will the oil improve the lives of many who are struggling with severe epilepsy and other medical conditions, but those who simply wish to add it as a supplement will also benefit nutritionally. Hemp is full of vitamins, minerals and omega-3 and omega-6 fatty acids.
The U.K. is one prime example of shifting attitudes and beliefs surrounding marijuana and its health benefits. For example, one recent petition in the country calling for the legalization of cannabis for medicinal and personal use garnered over 200,000 signatures in less than a week.
Supporters include the famous CNN doctor Sanjay Gupta, who is known for reversing his opinion on medical marijuana and is now one of its strongest advocates. Thanks to voices like his and the stories from parents of children like Charlotte all over the world, lawmakers are now also beginning to see the value of using cannabis products like Charlotte’s Web as valuable treatments for a variety of medical conditions.
photo credit: UK CBD
Recently, the Georgia legislature passed a law allowing very limited medical marijuana use in the state. The Haleigh’s Hope Act, which covers a short list of diseases and allows only CBD-rich cannabis oil to be used, offers hope to thousands of sufferers of epilepsy, multiple sclerosis, and other ailments.
Connecticut is considering a similar law. Unlike Georgia, Connecticut already allows limited whole plant medical marijuana (although it does not permit home cultivation, it does provide safe access via dispensaries). Parents of epileptic children, however, typically prefer to avoid the medical cannabis available legally in the state, which sometimes sports a THC level as high as 27 percent.
Although there’s certainly a heavy stigma attached to THC, the cannabinoid responsible for the euphoric high that accompanies use of conventional street marijuana, it’s understandable that most parents would prefer a CBD cannabis oil containing virtually no THC (CBD oils typically have as little as 0.3 percent THC and produce no psychoactive effect).
Marijuana for Children
The Connecticut bill, House Bill 5892 (“An Act Concerning the Palliative Use of Marijuana for Children”), has the sole purpose of helping children gain relief from life-threatening diseases like epilepsy and leukemia. Despite this — and recent media attention on the huge success of CBD treatment for epileptic children in Colorado and other parts of the country — this compassion bill faces opposition from multiple sources. Both Republican senator Toni Boucher and the Connecticut chapter of the American Academy of Pediatrics have vocally opposed it.
Despite the fact that the bill would permit children to be treated only with CBD oil, which has been shown to produce stunningly effective results in many children throughout the country, “Reefer Madness” fears of brain damage from marijuana still persist.
According to Senator Boucher, via a recent press release:
“The brain is still developing when a child is young. Studies show these substances can alter adolescent development and can permanently damage the health and cognitive function of a child’s brain. Children can lose memory and have a total change in their brain development. There is very conclusive medical science around this.”
AAP Slings Prohibitionist Rhetoric
The Connecticut chapter of the American Academy of Pediatrics (AAP) has echoed Boucher’s statements, also exploiting the issue of childhood brain development and the false perception that a cannabis extract like CBD oil inevitably causes brain damage and developmental harm to children.
In an op-ed article for The Connecticut Mirror, AAP representative Dr. Sheryl Ryan wrote:
“Given the negative effects of marijuana on brain development, and cognitive performance and mental health disorders, we should not be recommending and supporting such laws.”
The AAP has gone as far as stating that it believes the use of CBD oil by epileptic and other sick children will increase recreational use of cannabis among all children. Due to the fact that recreational use of marijuana by teens is a cultural and social phenomenon and there is no physical addiction whatsoever, statements like this from the AAP are especially troublesome and preposterous.
Flagrant Disregard for Evidence
The frustrating part of this opposition is that it flagrantly disregards well-publicized examples of CBD efficacy, like that of Colorado resident Charlotte Figi, the nine-year-old girl who went from nearly 400 seizures a week to being 99.7 percent seizure free. This was accomplished with nothing more than a CBD oil extract derived from a special strain of cannabis produced by CW Botanicals, the Colorado company that developed the CBD-based Charlotte’s Web “hemp extract” product, naming it after the patient who inspired its development.
If opponents are successful and able to defeat this bill, parents who have tried literally every conventional pharmaceutical medication and treatment available, but have found no relief, will be relegated to criminals who must deal with the black market.
Politicians and leaders who oppose full recreational legalization of cannabis are one thing. However, influential voices of authority, like Dr. Ryan and Senator Boucher, who so boldly oppose a parent’s desperate effort to give relief to their very sick children, is another. Given what is known about CBD efficacy for childhood epilepsy alone, such actions may be viewed by future generations as obscenely ignorant in the best light and borderline sadistic in the worst.
House Bill 5892 currently resides in the Joint Committee on Public Health in the Connecticut legislature. Will reason, compassion, and science defeat the fear mongering and antiquated prohibitionist rhetoric being offered by the American Academy of Pediatrics and conservative politicians like Toni Boucher? Will the legislature see beyond outdated thinking that forces both children and their parents and caretakers to needlessly suffer?